STRATA Skin Sciences, Inc. (SSKN)
USD 2.62
(-0.76%)
USD 2.62
(-0.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 33.35 Million USD | -7.75% |
| 2022 | 36.16 Million USD | 20.63% |
| 2021 | 29.97 Million USD | 29.83% |
| 2020 | 23.09 Million USD | -26.9% |
| 2019 | 31.58 Million USD | 5.8% |
| 2018 | 29.85 Million USD | -5.07% |
| 2017 | 31.44 Million USD | -0.97% |
| 2016 | 31.75 Million USD | 71.71% |
| 2015 | 18.49 Million USD | 1921.31% |
| 2014 | 915 Thousand USD | 70.71% |
| 2013 | 536 Thousand USD | 92.49% |
| 2012 | 278.46 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 210 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.75 Million USD | -22.27% |
| 2024 Q2 | 8.43 Million USD | 24.89% |
| 2023 FY | 33.35 Million USD | -7.75% |
| 2023 Q1 | 7.56 Million USD | -28.63% |
| 2023 Q3 | 8.85 Million USD | 7.3% |
| 2023 Q4 | 8.68 Million USD | -1.84% |
| 2023 Q2 | 8.25 Million USD | 9.03% |
| 2022 Q1 | 7.04 Million USD | -51.62% |
| 2022 FY | 36.16 Million USD | 20.63% |
| 2022 Q4 | 10.6 Million USD | 12.63% |
| 2022 Q3 | 9.41 Million USD | 3.38% |
| 2022 Q2 | 9.1 Million USD | 29.31% |
| 2021 Q3 | 7.71 Million USD | 4.46% |
| 2021 Q2 | 7.38 Million USD | 26.69% |
| 2021 Q1 | 5.82 Million USD | -13.25% |
| 2021 FY | 29.97 Million USD | 29.83% |
| 2021 Q4 | 14.55 Million USD | 88.76% |
| 2020 Q2 | 4.03 Million USD | -40.12% |
| 2020 Q1 | 6.73 Million USD | -24.37% |
| 2020 Q3 | 5.61 Million USD | 39.28% |
| 2020 FY | 23.09 Million USD | -26.9% |
| 2020 Q4 | 6.71 Million USD | 19.67% |
| 2019 Q2 | 7.72 Million USD | 3.23% |
| 2019 Q4 | 8.89 Million USD | 18.96% |
| 2019 Q1 | 7.48 Million USD | -6.03% |
| 2019 Q3 | 7.48 Million USD | -3.17% |
| 2019 FY | 31.58 Million USD | 5.8% |
| 2018 Q4 | 7.96 Million USD | 0.9% |
| 2018 Q2 | 7.53 Million USD | 16.5% |
| 2018 Q1 | 6.46 Million USD | -19.12% |
| 2018 FY | 29.85 Million USD | -5.07% |
| 2018 Q3 | 7.89 Million USD | 4.77% |
| 2017 Q3 | 7.48 Million USD | -14.04% |
| 2017 Q2 | 8.7 Million USD | 19.66% |
| 2017 Q1 | 7.27 Million USD | -15.75% |
| 2017 FY | 31.44 Million USD | -0.97% |
| 2017 Q4 | 7.99 Million USD | 6.89% |
| 2016 Q1 | 7.62 Million USD | -19.62% |
| 2016 Q4 | 8.63 Million USD | 11.12% |
| 2016 Q3 | 7.76 Million USD | 0.36% |
| 2016 FY | 31.75 Million USD | 71.71% |
| 2016 Q2 | 7.73 Million USD | 1.56% |
| 2015 Q4 | 9.48 Million USD | 13.9% |
| 2015 Q1 | 81.2 Thousand USD | -78.31% |
| 2015 FY | 18.49 Million USD | 1921.31% |
| 2015 Q3 | 8.32 Million USD | 1262.19% |
| 2015 Q2 | 611 Thousand USD | 652.46% |
| 2014 Q4 | 374.3 Thousand USD | 71.78% |
| 2014 FY | 915 Thousand USD | 70.71% |
| 2014 Q3 | 217.9 Thousand USD | -3.22% |
| 2014 Q2 | 225.15 Thousand USD | 130.6% |
| 2014 Q1 | 97.63 Thousand USD | -30.16% |
| 2013 Q1 | 144.1 Thousand USD | 17.8% |
| 2013 FY | 536 Thousand USD | 92.49% |
| 2013 Q4 | 139.79 Thousand USD | 29.79% |
| 2013 Q3 | 107.7 Thousand USD | -25.41% |
| 2013 Q2 | 144.39 Thousand USD | 0.21% |
| 2012 Q1 | 11.25 Thousand USD | 0.0% |
| 2012 FY | 278.46 Thousand USD | 0.0% |
| 2012 Q4 | 122.32 Thousand USD | 76.96% |
| 2012 Q3 | 69.12 Thousand USD | -8.75% |
| 2012 Q2 | 75.75 Thousand USD | 573.4% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | 186.55 Million USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 87.08 Million USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | 87.08 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | -100.0% |
| 2000 FY | 210 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -365.634% |
| Cerus Corporation | 156.36 Million USD | 78.667% |
| OrthoPediatrics Corp. | 148.73 Million USD | 77.572% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -3343.563% |
| Talis Biomedical Corporation | 412 Thousand USD | -7996.602% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -141.707% |
| Inogen, Inc. | 315.66 Million USD | 89.432% |
| Spectral AI, Inc. | 18.05 Million USD | -84.747% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -236.779% |
| CVRx, Inc. | 39.29 Million USD | 15.109% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -5079.814% |
| Orthofix Medical Inc. | 746.64 Million USD | 95.532% |
| Venus Concept Inc. | 76.35 Million USD | 56.311% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -176.623% |
| Bioventus Inc. | 512.34 Million USD | 93.489% |
| BrainsWay Ltd. | 31.78 Million USD | -4.949% |
| Envoy Medical, Inc. | 316 Thousand USD | -10456.329% |
| electroCore, Inc. | 16.03 Million USD | -108.097% |
| IceCure Medical Ltd | 3.22 Million USD | -933.075% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -1273.888% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -9039.203% |
| MaxCyte, Inc. | 41.28 Million USD | 19.207% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -1608.528% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -30020.633% |
| PAVmed Inc | 2.45 Million USD | -1260.44% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -48.133% |
| RxSight, Inc. | 89.07 Million USD | 62.552% |
| Sight Sciences, Inc. | 81.05 Million USD | 58.846% |
| SI-BONE, Inc. | 138.88 Million USD | 75.982% |
| TELA Bio, Inc. | 58.45 Million USD | 42.932% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -80.206% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 82.173% |
| LivaNova PLC | 1.15 Billion USD | 97.108% |
| 908 Devices Inc. | 50.22 Million USD | 33.588% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 93.083% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -43197.335% |
| NeuroPace, Inc. | 65.42 Million USD | 49.01% |
| LENSAR, Inc. | 42.16 Million USD | 20.885% |
| Apyx Medical Corporation | 52.34 Million USD | 36.278% |
| Cutera, Inc. | 212.36 Million USD | 84.292% |
| BioSig Technologies, Inc. | 18 Thousand USD | -185222.217% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 79.985% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -39.253% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 97.836% |
| Axonics, Inc. | 366.37 Million USD | 90.895% |
| Outset Medical, Inc. | 130.37 Million USD | 74.414% |
| IRIDEX Corporation | 51.86 Million USD | 35.688% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 75.506% |
| IRadimed Corporation | 65.56 Million USD | 49.12% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -2736.565% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1004.359% |
| Telesis Bio, Inc. | 27.5 Million USD | -21.262% |
| Viemed Healthcare, Inc. | 183 Million USD | 81.772% |
| Varex Imaging Corporation | 811 Million USD | 95.887% |
| Quipt Home Medical Corp. | 221.74 Million USD | 84.956% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 51.426% |
| Dynatronics Corporation | 32.53 Million USD | -2.533% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -284.397% |
| Semler Scientific, Inc. | 68.18 Million USD | 51.077% |
| InMode Ltd. | 492.04 Million USD | 93.221% |
| Bruker Corporation | 2.96 Billion USD | 98.875% |
| Cytosorbents Corporation | 36.34 Million USD | 8.23% |
| DexCom, Inc. | 3.62 Billion USD | 99.079% |
| Align Technology, Inc. | 3.86 Billion USD | 99.136% |
| Viveve Medical, Inc. | 6.42 Million USD | -419.11% |
| ZimVie Inc. | 457.43 Million USD | 92.708% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 82.717% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -30020.633% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 95.539% |
| Profound Medical Corp. | 7.33 Million USD | -355.025% |
| Insulet Corporation | 1.69 Billion USD | 98.034% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 73.542% |
| iCAD, Inc. | 17.31 Million USD | -92.62% |
| Nuwellis, Inc. | 8.86 Million USD | -276.331% |
| Biotricity, Inc. | 12.06 Million USD | -176.524% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 93.229% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -437.599% |
| PAVmed Inc. | 2.45 Million USD | -1260.44% |
| BIOLASE, Inc. | 49.16 Million USD | 32.15% |
| Beyond Air, Inc. | 1.15 Million USD | -2778.171% |
| FONAR Corporation | 102.88 Million USD | 67.577% |
| AxoGen, Inc. | 159.01 Million USD | 79.022% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 87.844% |
| Inari Medical, Inc. | 493.63 Million USD | 93.242% |
| UFP Technologies, Inc. | 400.07 Million USD | 91.662% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -179244.081% |
| Tenon Medical, Inc. | 2.92 Million USD | -1039.276% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -389.692% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.958% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1169.813% |
| NanoVibronix, Inc. | 2.28 Million USD | -1361.148% |
| Quanterix Corporation | 122.36 Million USD | 72.74% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -36.685% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 83.364% |
| TransMedics Group, Inc. | 241.62 Million USD | 86.194% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -140.782% |
| NeuroMetrix, Inc. | 5.9 Million USD | -465.253% |
| Hyperfine, Inc. | 11.03 Million USD | -202.375% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 79.802% |
| Biomerica, Inc. | 5.41 Million USD | -516.03% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 34.024% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 81.168% |